Fusion Antibodies is set to double its workforce as part of an investment supported by Invest NI.
Its planned expansion, which also includes doubling revenues with the next three years, will create 15 jobs.
Invest NI has provided Fusion Antibodies with £97,500 worth of support.
Fusion Antibodies Managing director Paul Kerr said: “In the past four years we have humanised more than 65 novel targets for pharma and biotech clients in Asia, Europe and the USA and we foresee major growth in this area.
“The 15 new staff will ensure that we are in a position to meet the growing demand for our services.
“We’re grateful to Invest NI for this support and for the support we’ve received in the past which has helped the company to establish itself as respected player in the antibody engineering arena.”
Economy minister Simon Hamilton said: “Fusion Antibodies is one of the most innovative companies in our growing life sciences sector.
“The company is now capitalising on its knowledge base with an ambitious target of doubling revenues within the next three years. The increased revenues, which will all be from export sales, together with the additional salaries of £368,000 a year which will be generated when the 15 new jobs are in place, are very positive news for the Northern Ireland economy.”